Mouse embryonic stem cells with aberrant transforming growth factor β signalling exhibit impaired differentiation in vitro and in vivo

Differentiation

Volumn 63, Issue 3, 1998, Pages 101-113

  Goumans, Marie José ^a   Ward van Oostwaard, Dorien ^a   Wianny, Florence ^a,b   Savatier, Pierre ^b   Zwijsen, An ^a,c   Mummery, Christine ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CYCLE; ECTODERM; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; INNER CELL MASS; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; TUMOR CELL LINE;

EID: 0031927207     PISSN: 03014681     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-0436.1998.6330101.x     Document Type: Article

References (57)

1. Akhurst RJ (1994) The transforming growth factor β family in vertebrate embryogenesis. In: Nilsen-Hamilton M (ed) Growth factors and signal transduction in development. Wiley-Liss, pp 97-122
2. Akhurst RJ, Lehnert SA, Faissner A, Duffle E (1980) TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108:645-656
3. Bader D, Masaki T, Fischman DA (1982) Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol 95:763-770
4. Bonyadi M, Rusholme SAB, Cousins FM, Su HC, Biron CA, Farrall M, Akhurst RJ (1997) Mapping of a major genetic modifier of embryonic lethally in TGFβ knockout mice. Nature Genetics 15:207-211
5. Chen Y, Lebrun JJ, Vale W (1996) Regulation of transforming growth factor β- and activin-induced transcription by mammalian Mad proteins. Proc Natl Acad Sci USA 93:12992-12997
6. de Winter JP, de Vries CJM, van Achterberg TAE. Ameerun RF, Feijen A, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijnden-van Raaij AJM (1996) Truncated activin type II receptors inhibit activin bioactivity by the formation of heteromeric complexes with activin type 1 receptors. Exp Cell Res 224:323-334
7. 1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 14:1891-1899
8. 1 knockout mice. Development 121:1845-1854
9. Eppert K, Schere SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis IL, Thomson GH, Wrana JL, Attisano L (1996) MADR2 maps to 18q21 and encodes a TGFβ-regulated Mad-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552
10. Friedrich G, Soriano P (1991) Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5:1513-1523
11. Handyside AH, O'Neill GT, Jones M, Hooper ML (1989) Use of BRL-conditioned medium in combination with feeder layers to isolate a diploid embryonal stem cell line. Roux's Arch Dev Biol 198:48-55
12. Ignotz RA, Massagué J (1986) Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337-4345
13. Johansson BM, Wile WV (1995) Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 15:141-151
14. Kalkhoven E, Roelen BA, de Winter JP, Mummery CL, van den Eijnden-van Raaij AJ, van der Saag PT, van der Burg B (1995) Resistance of transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6:1151-1161
15. Kispert A, Herrmann B (1994) Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos. Dev Biol 161:179-193
16. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774
17. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB (1994) Maternal rescue of TGFβ1 null mice. Science 264:1936-1938
18. Lin HY, Wang XF, Ng-Eaton K, Weinberg R, Lodish H (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785
19. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signalling. Cell 87:1215-1224
20. Martin G, Evans MJ (1975) Differentiation of clonal lines of tertocarcinoma cells: Formation of embryoid bodies in vitro. Proc Natl Acad Sci USA 72:1441
21. Massagué J (1996) TGFβ signalling: receptors, transducers, and mad proteins. Cell 85:947-950
22. Massagué J, Weis-Garcia F (1996) Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cane Surv 27:41-64
23. Millan FA, Denhez F, Kondaiah P, Akhurst RJ (1991) Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111:131-143
24. Moses HL, Serra R (1996) Regulation of differentiation by TGFβ. Curr Opin Gen Dev 6:581-586
25. Mummery CL, Feijen A, van der Saag PT, van den Brink CE, de Laut SW (1985) Clonal variants of differentiated P19EC cells exhibit FGF receptor kinase activity. Dev Biol 137: 161-170
26. Mummery CL, Feijen A, van den Brink CE, Moolenaar WH, de Laat SW (1986) Establishment of a differentiated mesodermal line P19EX cells expressing functional PDGF and EGF receptors. Exp Cell Res 165:229-242
27. Mummery CL, Feijen A, Freund F, Shen S (1990) Characteristics of embryonic stem cell differentiation: a comparison with two embryonal carcinoma cell lines. Cell Diff Dev 30:195-206
28. Mummery CL, van den Eijnden-van Raaij AJM (1993) Type β transforming growth factors and activins in differentiating embryonal carcinoma cells, embryonic stem cells and early embryonic development. Int J Dev Biol 37:169-182
29. Nagy A, Rossant J (1993) Production of completely ES cell-derived fetuses. In "Gene targeting A Practical approach" (Joyner AL (ed).). IRL PRESS, Oxford
30. Nagy A, Gozca E, Merentes Diaz E, Prideaux VR, Ivanyi E, Markkula M, Rossant J (1990) Embryonic stem cells alone are able to support fetal development in the mouse. Development 110:815-821
31. Nakao A, Imamura T, Souchelnytskyi S, Kawabala M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Helding CH, Miyazono K, ten Dijke P (1997) TGFβ receptor mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16:5353-5362
32. Oshima M, Oshima H, Taketo MM (1996) TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179:297-302
33. Paria BC, Dey SK (1990) Preimplantation embryos development in vitro: Cooperative interactions among embryos and role of growth factors. Proc Natl Acad Sci USA 87:4756-4760
34. Pelton RW, Dickinson ME, Moses HL, Hogan BL (1990) In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development 110:609-620
35. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI (1991) Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105
36. Roberts AB, Sporn MB (1990) The transforming growth factor-βs. In: Sporn MB, Roberts AB (eds) Peptide Growth Factors and their Receptors. Springer-Verlag, Berlin, pp 143-152
37. Roelen BAJ, Lin HY, Knezevic V, Freund E, Mummery CL (1994) Expression of TGFβs and their receptors during implantation and organogenesis of the mouse embryo. Dev Biol 166:716-728
38. Roelen BAJ, van Rooijen MA, Mummery CL (1997) Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev Dyn, 209:418-430
39. Roelen BAJ, Goumans MJ, Zwijsen A, Mummery CL (1998) Identification of two distinct functions for TGFβ in early mouse development. (Submitted for publication)
40. Savatier P, Huang S, Szekely L, Wiman KG, Samarut J (1994) Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9:809-818
41. Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J (1996) Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 12:309-322
42. Slager HG, Van Inzen W, Freund E, van den Eijnden-van Raaij AJM, Mummery CL (1993) Transforming growth factor β in the early mouse embryo: implications for the regulation of muscle formation and implantation. Dev Gen 14:212-224
43. Slager HG, Freund E, Bulting AMJ, Feijen A, Mummery CL (1993) Secretion of transforming growth factor β isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation. J Cell Phys 156:247-256
44. Smith AG, Hooper ML (1987) Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 121:1-9
45. Solter I, Knowles BB (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen, SSEA-1. Proc Natl Acad Sci USA 75:5565-5569
46. Sun L, Wu G, Wilson JK, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG (1994) Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269:26449-26455
47. te Riele H, Maandag ER, Clarke A, Hooper M, Berns A (1990) Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in ES cells. Nature 348:649-651
48. ten Dijke P, Yamashita H, Ichijo H, Franken P, Laiho M, Miyazono K, Heldin CH (1994) Characterization of type I receptors for transforming growth factor β and activin. Science 264:101-104
49. ten Dijke P, Miyazono K, Heldin CH (1996) Signalling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol 8:139-145
50. van Zoelen EJJ, Koornneef I, Holthuis JCM, Ward-van Oostwaard TMJ, Feijen A, de Poorter TL, Mummery CL, van Buul-Offers SC (1989) Production of insulin-like growth factors, platelet-derived growth factor, and transforming growth factors and their role in the density-dependent growth regulation of a differentiated embryonal carcinoma cell line. Endocrinology 124:2029-2041
51. Wang J, Sun LZ, Myerhoff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV, Brattain MG (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppresser activity in replication error-positive colon carcinoma. J Biol Chem 270:22044-22049
52. Weiler-Guettler H, Aird WC, Rayburn H, Husain M, Rosenberg RD (1996) Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos. Development 122:2271-2281
53. Wianny F, Real FX, Mummery CL, Van Rooijen M, Lahti J, Samarut J, Savatier P (1998) G1-phase regulators, cyclin D1, cyclin D2 and cyclin D3: up-regulation at gastrulation and dynamic expression during neuralation. Dev Dyn (in press)
54. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J (1992) TGF β signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014
55. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF β receptor. Nature 370:341-347
56. Wrana JL, Attisano L (1996) MAD-related proteins in TGF-β signalling. Trends Genet 12:493-496
57. Zhang Y, Feng X-H, Wu RY, Derynck R (1996) Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-2108